CCEL Stock Analysis: Buy, Sell, or Hold?
CCEL - Cryo-Cell International Inc.
$3.45
-0.13 (-3.54%)
▼
5d:
-1.34%
30d:
-6.67%
90d:
+2.17%
BUY
MODERATE Confidence
Analysis Updated: May 8, 2026 12:00 AM ET
Earnings: Apr 21, 2026
0d
Get Alerted When CCEL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: CCEL shows positive signals but monitor for confirmation. Market pricing in 1.4% decline. Moderate conviction.
💡 BUY OPPORTUNITY: CCEL shows positive signals but monitor for confirmation. Market pricing in 1.4% decline. Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: CCEL is currently trading at $3.45, which is considered slightly low relative to its 30-day fair value range of $3.44 to $3.74. The stock's valuation (Forward PE: 172.7) is in line with its historical norms (180.1). Remarkably, the market is currently pricing in an annual earnings decline of 1.4% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, CCEL is showing sideways momentum. The price is currently testing key support at $3.41. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.5% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $8.50 (+146.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, CCEL is showing sideways momentum. The price is currently testing key support at $3.41. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.5% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $8.50 (+146.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$3.44 -
$3.74
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.8%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.5%)
- BULLISH: Trading 146.1% below Wall St target ($8.50)
Trading Range Analysis
30-Day Trading Range
$3.44 -
$3.74
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$3.41
Resistance Level
$4.10
Current Trend
Sideways
Technical data as of
May 8, 2026
Fundamental Context
Forward P/E (Next Year Est.)
172.66
Wall Street Target
$8.50
(+146.1%)
Revenue Growth (YoY)
-3.6%
Earnings Growth (YoY)
-80.5%
Profit Margin
-8.5%
Valuation Discount vs History
-1.4% cheaper
PE vs Historical
172.7 vs 180.1
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-1.4%
(market-implied from PE analysis)
1-Year Target
$3.40
(-1%)
2-Year Target
$3.36
(-3%)
3-Year Target
$3.31
(-4%)
3-Yr Target (if PE normalizes)
(PE: 173→180)
$3.45
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 172.7, Growth: -81.8%)
$2.52
(+-27%)
Base:
(SPY PE: 21.9, Growth: -81.8%)
$0.32
(-91%)
Bear:
(PE: 18.6, Growth: -81.8%)
$0.27
(-92%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 172.7 to 180.1
Stabilization Target:
$3.60
(+4.3%)
PE Expansion Potential:
+4.3%
Share & Embed Analysis
Last updated: May 10, 2026 12:38 PM ET
Data refreshes hourly during market hours. Next update: 1:38 PM
Data refreshes hourly during market hours. Next update: 1:38 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CCEL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$246 | 62 BUY |
|
HCA
HCA Holdings Inc |
BUY
25 analysts |
$513 | 56 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$141 | 58 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$21 | 61 BUY |
|
ADUS
Addus HomeCare Corporati… |
STRONG BUY
11 analysts |
$133 | 57 HOLD |
